ABSTRACT
INTRODUCTION
Benzalkonium chloride is a disinfectant used to prevent the spread of nosocomial infections through hospital instruments (McDonnel and Russell, 1999; Fazlara and Ekhtelat, 2012) . Benzalkonium chloride is a Quaternary Ammonium Compound (QAC) that works as a disinfectant by damaging the phospholipid bilayer of the bacterial cell, then entering into the cell and denaturing the essential proteins and inactivating the metabolic enzymes required by the cell. The destruction of cell and enzyme proteins then causes cell death (Rutala and Weber, 2008) .
Hospital-Associated Methicillin Resistant Staphylococcus aureus (HA-MRSA) is one of the bacteria that cause nosocomial infections (Gordon and Lowy, 2008) . The source of MRSA transmission can be from carrier individuals or contaminated instruments (Otto, 2012; Watkins et al., 2012; Bellows et al., 2013) . MRSA is a S. aureus strain that is resistant to methicillin and other β-lactam class antibiotics (e.g. penicillin and cephalosporin) (Todar et al., 2000) . MRSA is resistant to methicillin because it has a mecA gene which is located in a large chromosome element called SCCmec. The mode of resistance of MRSA to antibiotics is a change in Penicillin Binding Protein (PBP) so that it is resistant to beta-lactam class antibiotics (Watkins et al., 2012) . The most common HA-MRSA causing nosocomial infection is Staphylococcal Cassette Chromosome mecA (SCCmec) type III, which composed 94.4% of all the HA-MRSA (Ashgar, 2014; Santosaningsih et al., 2014) , and 98% in Dr. Soetomo Hospital Surabaya (Lelitawati, 2016) . Because of its high prevalence, the HA-MRSA type which is used in this research is HA-MRSA with SCCmec type III.
Benzalkonium chloride is generally used as a disinfectant for hospital instruments to rid them of ISSN (print): 1823 -8262, ISSN (online): 2231 microorganisms, such as MRSA (Al-Masaudi et al., 1988) . However, there have been reported MRSA strains resistant to benzalkonium chloride which were isolated from Kyushu University Hospital, Japan (Akimitsu et al., 1999) . Meanwhile, there is lack of study concerning the presence of MRSA strains, especially HA-MRSA (including type III), which are resistant to benzalkonium chloride in Indonesia. This study determined the effectiveness of benzalkonium chloride in various concentrations as disinfectant against HA-MRSA with SCCmec type III.
MATERIALS AND METHODS

Ethical clearance
Ethical clearance for this research was obtained from Ethical Committee of Faculty of Medicine Universitas Airlangga with the ethical clearance certificate number 183/EC/KEPK/FKUA/2016.
Bacterial isolates
Five samples of MRSA bacterial isolates were obtained from the isolates taken from the patients who were admitted to Dr. Soetomo Hospital Surabaya with MRSA infection and then stored in the Laboratory of Clinical Microbiology (No. 183/EC/KEPK/FKUA/2016).
Determination of SCCmec type
To identify HA-MRSA with SCCmec type III, a confirmatory test was performed using multiplex PCR method (Milheirico et al., 2007) The HA-MRSA SCCmec type III identification method above was based on methods used in Murakami et al. (1991) , Zhang et al. (2005) and Milheirico et al. (2007) . The reagent used for DNA isolation was obtained from iNtRON Biotechnology, Korea. PCR was performed using GoTaq Green Master Mix reagent (Promega, United States of America) and processed with a thermocycler from Bio-Rad, United States of America.
Preparation of medium containing benzalkonium chloride
A 0.1 % solution of benzalkonium chloride was prepared by mixing 10 μL benzalkonium chloride (80%) from Brataco, Indonesia and 7990 μL aquadest into the test tube, then the solution was mixed using micropipette. The amount of 0.1% benzalkonium chloride used for each concentration is 0 μL for 0 μg/mL as a positive control (group 1), 12.5 μL for 0.625 μg/mL (group 2), 25 μL for 1.25 μg/mL (group 3), 50 μL for two media, which are 2.5 μg/mL (group 4) and as a negative control (group 7), 100 μL for 5 μg/mL (group 5), 200 μL for 10 μg/mL (group 6). Six groups were inoculated with MRSA (groups 1-6) and one group is not (group 7). All media were prepared by mixing 0.1% benzalkonium chloride according to the required amount with previously sterilized liquid nutrient agar in the Petri dish with the final volume of medium 20 mL. The Petri dish was then placed in room temperature (25 °C) for 15 min until the nutrient agar was solidified and then incubated in 37 °C for 24 h (Akimitsu et al., 1999) .
Preparation of bacterial suspension
The colony of HA-MRSA isolate number 646 was taken from agar plate with a sterile loop needle and suspended into a nutrient broth medium in a test tube until it reached 0.5 McFarland turbidity, then the suspension was mixed using vortex. The homogeneous suspension was further diluted six times by 4 mL dilution in nutrient broth medium (final concentration of bacteria: Approx. 10 6 -10 7 CFU/mL) (Garcia, 2010) .
Inoculation of bacteria
Fifty microliter suspension of diluted bacteria was dripped using micropipette onto the agar medium that has been solidified in a Petri dish (except the medium for negative control). The bacterial suspension was then spread using a sterile spreader. The bacterial-inoculated medium was kept at room temperature until the bacterial suspension on the medium dried, then incubated at 37 °C for 24 h (Akimitsu et al., 1999) . Four replications were performed on each concentration of benzalkonium chloride that was tested.
Counting colonies
Colony counting was done using BZG 40 colony counter from Hoskin Scientific, Canada. Due to the non-scaling calculations (in some of the Petri dish, the bacteria formed a fog-like growth, so the number of colonies could not be counted), the results of the colony count were converted to ordinal data, with 0 representing 0 colonies from 50 μL of suspension (0 CFU/mL), +1 representing 10-100 colonies from 50 μL of suspension (200-2,000 CFU/mL), +2 representing 100-1,000 colonies from 50 μL of suspension (2,000-20,000 CFU/mL), and +3 representing more than 1,000 colonies from 50 μL of suspension (>20,000 CFU/mL) or fog-like growth (Brugger et al., 2012) .
MIC determination
The effectiveness of benzalkonium chloride as a disinfectant against HA-MRSA was calculated in the number of colonies grown on each agar nutrient medium. The Minimum Inhibitory Concentration (MIC) was determined by the result of the colony counting. MIC of benzalkonium chloride against MRSA was the concentration of benzalkonium chloride in the medium with zero colonies of MRSA growth (Akimitsu et al., 1999) .
Data analysis
Data which was obtained from seven groups was processed using IBM SPPS Statistics 23 with KruskallWallis comparative test to determine the difference of HA-MRSA growth on media with different benzalkonium chloride concentration. Spearman correlation test was used to find out the correlation between benzalkonium chloride concentration and HA-MRSA growth.
RESULTS
HA-MRSA identification
There were five isolates tested, isolates numbered 448, 575, 646, 686, and 700. Results of PCR of those 5 MRSA isolates are shown in Figure 1. 
Benzalkonium chloride sensitivity test
Isolate number 646 was then tested for its sensitivity to benzalkonium chloride. The results of HA-MRSA growth on nutrient agar medium containing six different concentrations of benzalkonium chloride is shown in Figure 2 . The number of HA-MRSA colonies which grew on each nutrient agar medium is shown in Table 1 . The number of colonies was then converted to ordinal data and is shown in Figure 2 . The graph showing the mean values of the number of HA-MRSA colonies which grew on each nutrient agar medium is shown in Figure 3 . Figure 2 , Table 1 , and Figure 3 show that the MIC of benzalkonium chloride for HA-MRSA with SCCmec type III was 5 μg/mL because benzalkonium chloride in that concentration was effective to to kill all bacteria inoculated in the media. There is a significant relationship between the concentration of benzalkonium chloride with the growth of HA-MRSA when analyzed by Spearman correlation test. It showed the value of significance at 0.0001 (p<0.05). The correlation coefficient obtained was -0.880, which means the negative correlation between the two variables was strong (>0.75 or <-0.75). The higher concentration of benzalkonium chloride will decrease the growth of HA-MRSA. The negative correlation is shown in Figure 4 .
DISCUSSION
Minimum Inhibitory Concentration (MIC) of benzalkonium chloride against HA-MRSA isolate with SCCmec type III obtained from Dr. Soetomo Hospital Surabaya was 5 μg/mL. This MIC was similar to the MIC of benzalkonium chloride against benzalkonium chloride-sensitive MRSA in a research conducted in Japan by Akimitsu in 1999. According to the research, HA-MRSA with SCCmec type III used in this study had no resistance to benzalkonium chloride but has definitely been resistant to antibiotic methicillin because it has mecA gene that encodes resistance to methicillin in all MRSAs.
Previous tests of HA-MRSA isolated from various hospitals in Rome, Italy, resulted in benzalkonium chloride having different MICs on the various HA-MRSA strains tested. The MICs were 2 μg/mL, 4 μg/mL, 8 μg/mL, and 16 μg/mL (Raggi and Filippini, 2013) . These results suggested that different gene mutations between different HA-MRSA strains may also affect the resistance of HA-MRSA to benzalkonium chloride. This is the reason why this research is important to be conducted.
Research on the effectiveness of benzalkonium chloride as a disinfectant against MRSA has been done before. From these studies, it can be observed that MRSA resistance to benzalkonium chloride is associated with MRSA resistance to certain antibiotics (Fatholahzadeh et al., 2008; Ahmad et al., 2013) . This happens because both have the same resistance mechanism, that is through the efflux pump encoded by the same gene (Ubarretxena-Belandia, 2003; Weinstein et al., 2005; Quistgaard et al., 2016) . Mutation of genes that cause MRSA resistance to benzalkonium chloride is a mutation of the femA gene that also causes resistance to methicillin and oxacillin (Akimitsu et al., 1999) , as well as qac gene mutations that also lead to erythromycin, penicillin and ampicillin resistance (He et al., 2014) . From the studies it can be concluded that MRSA resistance mechanisms to various types of antibiotics and disinfectants, especially benzalkonium chloride, are not only caused by mutations of one particular gene, but there are several gene mutations that play a role (Reiter et al., 2010) . Gene mutations in MRSA that cause resistance towards antibiotics are influenced by environmental condition and frequent use of disinfectants (He et al., 2014) . The MIC of benzalkonium chloride against HA-MRSA might be different at places other than health care institutions, because the MIC is also influenced by previous benzalkonium chloride exposure towards the microorganism (He et al., 2014) . Thus, the MIC of benzalkonium chloride against MRSA at places other than health care institutions are probably different than those at health care institutions which use benzalkonium chloride frequently as disinfectant.
Different types of MRSA and MRSA growing in different environments are likely to have different gene mutations and patterns of resistance to different antibiotics and disinfectants. This is the reason why researches of effectivity of benzalkonium chloride against HA-MRSA has been done in various countries and environments using many different types of MRSA, including in Indonesia using HA-MRSA with SCCmec type III as was done in this research.
Contamination of hospital equipment by HA-MRSA will cause nosocomial infection if those contaminated equipment are exposed to the patients. Patients with nosocomial infection caused by HA-MRSA will be difficult to treat using antibiotics, because HA-MRSA has been proven resistant towards numerous antibiotics, such as methicillin. Thus, the application of benzalkonium chloride as disinfectant is important to prevent the nosocomial infection caused by methicillin resistant bacteria (Mollema et al., 2010; Otto, 2012) .
There are some limitations in this study. First, this research only used one strain of MRSA, which is HA-MRSA with SCCmec type III, and second, this study was only conducted at Dr. Soetomo Hospital, Surabaya. However, the result of this research can be used as initial data for further studies concerning MRSA resistance towards benzalkonium chloride in Indonesia.
CONCLUSION
In conclusion, HA-MRSA isolated from Dr. Soetomo Hospital Surabaya is still sensitive to benzalkonium chloride with concentration 5 μg/mL. This concentration can be implemented not only at Dr. Soetomo Hospital Surabaya, but also at another health care institutions in and around Surabaya.
